174 related articles for article (PubMed ID: 19109928)
1. Skp2 promotes adipocyte differentiation via a p27Kip1-independent mechanism in primary mouse embryonic fibroblasts.
Okada M; Sakai T; Nakamura T; Tamamori-Adachi M; Kitajima S; Matsuki Y; Watanabe E; Hiramatsu R; Sakaue H; Kasuga M
Biochem Biophys Res Commun; 2009 Feb; 379(2):249-54. PubMed ID: 19109928
[TBL] [Abstract][Full Text] [Related]
2. Skp2-mediated p27(Kip1) degradation during S/G2 phase progression of adipocyte hyperplasia.
Auld CA; Fernandes KM; Morrison RF
J Cell Physiol; 2007 Apr; 211(1):101-11. PubMed ID: 17096381
[TBL] [Abstract][Full Text] [Related]
3. The F box protein S phase kinase-associated protein 2 regulates adipose mass and adipocyte number in vivo.
Cooke PS; Holsberger DR; Cimafranca MA; Meling DD; Beals CM; Nakayama K; Nakayama KI; Kiyokawa H
Obesity (Silver Spring); 2007 Jun; 15(6):1400-8. PubMed ID: 17557977
[TBL] [Abstract][Full Text] [Related]
4. Growth arrest by troglitazone is mediated by p27Kip1 accumulation, which results from dual inhibition of proteasome activity and Skp2 expression in human hepatocellular carcinoma cells.
Motomura W; Takahashi N; Nagamine M; Sawamukai M; Tanno S; Kohgo Y; Okumura T
Int J Cancer; 2004 Jan; 108(1):41-6. PubMed ID: 14618613
[TBL] [Abstract][Full Text] [Related]
5. STAT1 represses Skp2 gene transcription to promote p27Kip1 stabilization in Ras-transformed cells.
Wang S; Raven JF; Koromilas AE
Mol Cancer Res; 2010 May; 8(5):798-805. PubMed ID: 20407011
[TBL] [Abstract][Full Text] [Related]
6. Bortezomib (Velcade) induces p27Kip1 expression through S-phase kinase protein 2 degradation in colorectal cancer.
Uddin S; Ahmed M; Bavi P; El-Sayed R; Al-Sanea N; AbdulJabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Hussain AR; Al-Kuraya KS
Cancer Res; 2008 May; 68(9):3379-88. PubMed ID: 18451165
[TBL] [Abstract][Full Text] [Related]
7. Skp2 inversely correlates with p27 and tuberin in transformed cells.
Rosner M; Hanneder M; Siegel N; Valli A; Fuchs C; Hengstschläger M
Amino Acids; 2009 Jul; 37(2):257-62. PubMed ID: 18604603
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic properties and prognostic implications of the ubiquitin ligase Skp2 in cancer.
Hershko DD
Cancer; 2008 Apr; 112(7):1415-24. PubMed ID: 18260093
[TBL] [Abstract][Full Text] [Related]
9. Evidence for cytosolic p27(Kip1) ubiquitylation and degradation during adipocyte hyperplasia.
Auld CA; Morrison RF
Obesity (Silver Spring); 2006 Dec; 14(12):2136-44. PubMed ID: 17189539
[TBL] [Abstract][Full Text] [Related]
10. [Expression variation and significance of Skp2 and p27(kip1) during the proliferation of Jurkat cells].
Lu JX; Wang YC; Shen AG; Zhao YM; Sun CL; Zhang DM; Cheng C
Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):330-4. PubMed ID: 18953829
[TBL] [Abstract][Full Text] [Related]
11. p27Kip1 repression of ErbB2-induced mammary tumor growth in transgenic mice involves Skp2 and Wnt/beta-catenin signaling.
Hulit J; Lee RJ; Li Z; Wang C; Katiyar S; Yang J; Quong AA; Wu K; Albanese C; Russell R; Di Vizio D; Koff A; Thummala S; Zhang H; Harrell J; Sun H; Muller WJ; Inghirami G; Lisanti MP; Pestell RG
Cancer Res; 2006 Sep; 66(17):8529-41. PubMed ID: 16951165
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemically detected expression of p27(Kip1) and Skp2 predicts survival in patients with intrahepatic cholangiocarcinomas.
Hashimoto N; Yachida S; Okano K; Wakabayashi H; Imaida K; Kurokohchi K; Masaki T; Kinoshita H; Tominaga M; Ajiki T; Ku Y; Okabayashi T; Hanazaki K; Hiroi M; Izumi S; Mano S; Okada S; Karasawa Y; Maeba T; Suzuki Y
Ann Surg Oncol; 2009 Feb; 16(2):395-403. PubMed ID: 19034576
[TBL] [Abstract][Full Text] [Related]
13. A novel route for connexin 43 to inhibit cell proliferation: negative regulation of S-phase kinase-associated protein (Skp 2).
Zhang YW; Nakayama K; Nakayama K; Morita I
Cancer Res; 2003 Apr; 63(7):1623-30. PubMed ID: 12670914
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of cell proliferation of Tenon's capsule fibroblast by S-phase kinase-interacting protein 2 targeting SiRNA through increasing p27 protein level.
Wang F; Qi LX; Su Y; Yan QH; Teng Y
Invest Ophthalmol Vis Sci; 2010 Mar; 51(3):1475-82. PubMed ID: 19875654
[TBL] [Abstract][Full Text] [Related]
15. Expression of the F-box protein SKP2 induces hyperplasia, dysplasia, and low-grade carcinoma in the mouse prostate.
Shim EH; Johnson L; Noh HL; Kim YJ; Sun H; Zeiss C; Zhang H
Cancer Res; 2003 Apr; 63(7):1583-8. PubMed ID: 12670908
[TBL] [Abstract][Full Text] [Related]
16. p27 deregulation by Skp2 overexpression induced by the JAK2V617 mutation.
Furuhata A; Kimura A; Shide K; Shimoda K; Murakami M; Ito H; Gao S; Yoshida K; Tagawa Y; Hagiwara K; Takagi A; Kojima T; Suzuki M; Abe A; Naoe T; Murate T
Biochem Biophys Res Commun; 2009 Jun; 383(4):411-6. PubMed ID: 19364496
[TBL] [Abstract][Full Text] [Related]
17. Novel effect of helenalin on Akt signaling and Skp2 expression in 3T3-L1 preadipocytes.
Auld CA; Hopkins RG; Fernandes KM; Morrison RF
Biochem Biophys Res Commun; 2006 Jul; 346(1):314-20. PubMed ID: 16750815
[TBL] [Abstract][Full Text] [Related]
18. p27 is regulated independently of Skp2 in the absence of Cdk2.
Kotoshiba S; Gopinathan L; Pfeiffenberger E; Rahim A; Vardy LA; Nakayama K; Nakayama KI; Kaldis P
Biochim Biophys Acta; 2014 Feb; 1843(2):436-45. PubMed ID: 24269842
[TBL] [Abstract][Full Text] [Related]
19. Growth inhibition of a tongue squamous cell carcinoma cell line (Tca8113) in vitro and in vivo via siRNA-mediated down-regulation of skp2.
Fang L; Hu Q; Hua Z; Li S; Dong W
Int J Oral Maxillofac Surg; 2008 Sep; 37(9):847-52. PubMed ID: 18620845
[TBL] [Abstract][Full Text] [Related]
20. Stromelysin-3 is a potent negative regulator of adipogenesis participating to cancer cell-adipocyte interaction/crosstalk at the tumor invasive front.
Andarawewa KL; Motrescu ER; Chenard MP; Gansmuller A; Stoll I; Tomasetto C; Rio MC
Cancer Res; 2005 Dec; 65(23):10862-71. PubMed ID: 16322233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
